Centre for Eye Research Australia

Running trials

• Recruiting

  Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

  NCT06825702· Phase 2· Source

• Not yet recruiting

  Functional Assessments in Vision Impairment

  NCT06908161· Source

• Active, not recruiting

  A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT06795048· Phase 4· Source

• Recruiting

  Defining Retinal Structures Using Hyperspectral Retinal Imaging

  NCT07555574· Source

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Source

• Active, not recruiting

  Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

  NCT06116916· Phase 2· Source

• Recruiting

  Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

  NCT05589714· Source

• Active, not recruiting

  Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

  NCT05610319· Phase 4· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Source

• Active, not recruiting

  An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

  NCT05300724· Source

• Enrolling by invitation

  Longitudinal Study of a Bionic Eye

  NCT05158049· Source

• Recruiting

  Retinal Hyperspectral Imaging in Neurodegenerative Diseases

  NCT07545473· Source

• Active, not recruiting

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· Phase 3· Source

• Recruiting

  Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

  NCT04739319· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration4 recruiting
• Retinitis pigmentosa3 recruiting
• Diabetic eye disease2 recruiting
• Glaucoma2 recruiting
• Alzheimer disease1 recruiting
• Frontotemporal dementia1 recruiting
• Lewy body dementia1 recruiting
• Parkinson disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

  NCT06116890· Phase 2· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Source

• Completed

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· Phase 3· Source

• Terminated

  Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study

  NCT05200624· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Source

• Completed

  Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

  NCT04576689· Phase 2· Source

• Completed

  Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma

  NCT04060758· Phase 1· Source

• Terminated

  Detecting Beta-amyloid in the Retina

  NCT07529912· Source

Trial sites

• Centre for Eye Research Australia18 trials
• Centre for Eye Research Australia1 trial
• The Centre for Eye Research Australia3 trials
• Centre for Eye Research Australia1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Glaucoma41 works · 3 trials
• Macular degeneration31 works · 14 trials